Logo image of VHC

VIRNETX HOLDING CORP (VHC) Stock Fundamental Analysis

NYSE:VHC - New York Stock Exchange, Inc. - US92823T2078 - Common Stock - Currency: USD

10.83  +1.08 (+11.08%)

After market: 7.5 -3.33 (-30.75%)

Fundamental Rating

2

Overall VHC gets a fundamental rating of 2 out of 10. We evaluated VHC against 282 industry peers in the Software industry. No worries on liquidiy or solvency for VHC as it has an excellent financial health rating, but there are worries on the profitability. VHC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VHC had negative earnings in the past year.
VHC had a negative operating cash flow in the past year.
VHC had negative earnings in 4 of the past 5 years.
In the past 5 years VHC reported 4 times negative operating cash flow.
VHC Yearly Net Income VS EBIT VS OCF VS FCFVHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of VHC (-38.93%) is worse than 79.58% of its industry peers.
VHC has a worse Return On Equity (-48.30%) than 67.25% of its industry peers.
Industry RankSector Rank
ROA -38.93%
ROE -48.3%
ROIC N/A
ROA(3y)-35.49%
ROA(5y)-2.01%
ROE(3y)-39.82%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
VHC Yearly ROA, ROE, ROICVHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VHC Yearly Profit, Operating, Gross MarginsVHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100K -100K -200K -300K -400K

More info and screens

7

2. Health

2.1 Basic Checks

VHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VHC has more shares outstanding
Compared to 5 years ago, VHC has more shares outstanding
There is no outstanding debt for VHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VHC Yearly Shares OutstandingVHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
VHC Yearly Total Debt VS Total AssetsVHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

VHC has an Altman-Z score of -3.88. This is a bad value and indicates that VHC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.88, VHC is not doing good in the industry: 79.58% of the companies in the same industry are doing better.
There is no outstanding debt for VHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.88
ROIC/WACCN/A
WACC8.93%
VHC Yearly LT Debt VS Equity VS FCFVHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

VHC has a Current Ratio of 17.72. This indicates that VHC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 17.72, VHC belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
A Quick Ratio of 17.72 indicates that VHC has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 17.72, VHC belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 17.72
Quick Ratio 17.72
VHC Yearly Current Assets VS Current LiabilitesVHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.82% over the past year.
Looking at the last year, VHC shows a very strong growth in Revenue. The Revenue has grown by 50.00%.
The Revenue for VHC have been decreasing by -43.90% on average. This is quite bad
EPS 1Y (TTM)36.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.53%
Revenue 1Y (TTM)50%
Revenue growth 3Y-50%
Revenue growth 5Y-43.9%
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VHC Yearly Revenue VS EstimatesVHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
VHC Yearly EPS VS EstimatesVHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VHC. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VHC Price Earnings VS Forward Price EarningsVHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VHC Per share dataVHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VIRNETX HOLDING CORP

NYSE:VHC (6/27/2025, 8:04:00 PM)

After market: 7.5 -3.33 (-30.75%)

10.83

+1.08 (+11.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-12 2025-08-12
Inst Owners10.89%
Inst Owner Change-8%
Ins Owners13.88%
Ins Owner Change5.15%
Market Cap45.92M
Analysts0
Price TargetN/A
Short Float %3.7%
Short Ratio13.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15306.4
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB 1.26
EV/EBITDA N/A
EPS(TTM)-4.88
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.71
FCFYN/A
OCF(TTM)-3.7
OCFYN/A
SpS0
BVpS8.58
TBVpS8.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.93%
ROE -48.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.49%
ROA(5y)-2.01%
ROE(3y)-39.82%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.72
Quick Ratio 17.72
Altman-Z -3.88
F-Score6
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)456.19%
Cap/Sales(5y)273.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.53%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)50%
Revenue growth 3Y-50%
Revenue growth 5Y-43.9%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-0.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.67%
OCF growth 3YN/A
OCF growth 5YN/A